retatrutide patent expiration Obesity Drugs Set To Take Off, Expires In 2 Days China's weight-loss drug makers take

Key findings include that more than 70% believe compounded GLP-1s are only on the market if they have been tested and proven safe, and more than half (53%) think compounded GLP-1s have received FDA-approval

We mean this sincerely: the worst research decision is selecting a compound because a comparison guide labelled it 'better' without defining better for what

I believe the rush toward higher doses reflects a common misconception that more equals better

The SELECT Trial Participant profile: 17,604 participants who were all over 45, had a body-mass index (BMI) of 27 or above, did not have diabetes, and had established cardiovascular disease, such as a prior heart attack or stroke

The table below details the complete chemical footprint of the molecule for validation purposes